APA (7th ed.) Citation

Powderly, J., Shimizu, T., Lorusso, P., Razak, A., Miller, K., Balar, A., . . . Tolcher, A. (2020). 596TiP Phase I first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumours. Annals of Oncology, 31, S499. https://doi.org/10.1016/j.annonc.2020.08.710

Chicago Style (17th ed.) Citation

Powderly, J., et al. "596TiP Phase I First-in-human Study of ABBV-151 as Monotherapy or in Combination with Budigalimab in Patients with Locally Advanced or Metastatic Solid Tumours." Annals of Oncology 31 (2020): S499. https://doi.org/10.1016/j.annonc.2020.08.710.

MLA (9th ed.) Citation

Powderly, J., et al. "596TiP Phase I First-in-human Study of ABBV-151 as Monotherapy or in Combination with Budigalimab in Patients with Locally Advanced or Metastatic Solid Tumours." Annals of Oncology, vol. 31, 2020, p. S499, https://doi.org/10.1016/j.annonc.2020.08.710.